课题基金 / 基金详情

Characteristics and novel functions of SLC44A transporters

Characteristics and novel functions of SLC44A transporters
SLC44A转运蛋白的特点和新功能
批准号:
RGPIN-2020-04573
负责人:
Bakovic, Marica
金额:
$2.4万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

Bakovic, Marica的其他基金

相似基金

相关文献

中文摘要
翻译
磷脂酰胆碱(PC)和磷脂酰乙醇胺(PE)是参与细胞分裂、生存和信号传导基本过程的膜磷脂。PC和PE是通过cdp -胆碱和cdp -乙醇胺(Kennedy)途径重新合成的,其中细胞外底物胆碱和乙醇胺被转运到细胞内磷酸化,并与二酰基甘油偶联形成最终的磷脂产物。虽然胆碱的多种运输系统已经建立,但乙醇胺的运输特性却很差,并且没有单一的蛋白质分配给乙醇胺的运输功能。我们研究了来自溶质载体44A (SLC44A)家族的转运蛋白,即胆碱转运蛋白-1和-2 (CTL1和CTL2)。CTL1/SLC44A1是一种胆碱/质子反转运蛋白,为cdp -胆碱途径和胆碱氧化生成甜菜碱提供胆碱。有迹象表明CTL2/SLC44A2也是质膜和线粒体的胆碱转运体,但其功能尚未确定。我们提出:i. CTL1和CTL2是真正的质膜和线粒体乙醇胺转运体——我们将在维持CTL1但缺乏CTL2的细胞中表征CTL1和CTL2的细胞和线粒体转运,反之亦然。我们将利用CTL1/2突变体、siRNA和特异性抗体首次证明CTL1和CTL2在哺乳动物系统中是胆碱和乙醇胺转运体。2。CTL1和CTL2调节线粒体功能-我们的初步数据表明,CTL1的缺失诱导线粒体自噬和线粒体网络的断裂。我们提出CTL1调节线粒体融合-裂变过程。我们将研究CTL1和CTL2缺陷和过表达细胞中线粒体融合和代谢(电子传递复合物、ATP合成、ROS产生、膜电位等)的机制。初步发现将在从CTL1和/或CTL2敲除小鼠中分离的线粒体和原代细胞中得到证实。我们希望首次证明CTL1和CTL2是线粒体周转和线粒体能量稳态的关键调节因子。3。CTL1和CTL2偶联磷脂合成与全身能量代谢-CTL1和CTL2敲除小鼠产生和表征由国际小鼠表型联盟。体重减轻和肌脂比增加是CTL1和CTL2基因敲除小鼠的共同特征。我们将对CTL1小鼠进行详细的表征,并将其与更知名的CTL2小鼠进行比较,包括对骨骼肌、肝脏和脂肪组织中肯尼迪途径、脂质合成和能量代谢的调节,并应用先前在Pcyt2敲除小鼠(Pcyt2是cdp -乙醇胺肯尼迪途径的主要调节酶)研究中广泛使用的方案。
英文摘要
Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are membrane phospholipids involved in the fundamental processes of cell division, survival and signaling. PC and PE are synthesized de novo by the CDP-choline and CDP-ethanolamine (Kennedy) pathway, in which the extracellular substrates choline and ethanolamine are transported into the cell, phosphorylated, and coupled with diacylglycerol to form the final phospholipid product. While multiple transport systems have been established for choline, ethanolamine transport is poorly characterized, and there is no single protein assigned a transport function for ethanolamine. We investigate transporters from the family of Solute Carriers 44A (SLC44A) known as Choline Transporter-Like proteins-1 and -2 (CTL1 and CTL2). CTL1/SLC44A1 is a choline/proton antiporter and delivers choline for the CDP-choline pathway and choline oxidation to betaine. There are indications that CTL2/SLC44A2 is also a choline transporter at the plasma membrane and mitochondria, but its function is not firmly established. We propose that i. CTL1 and CTL2 are authentic plasma membrane and mitochondria ethanolamine transporters -We will characterize cellular and mitochondrial transport of CTL1 and CTl2 in cells that maintain CTL1 but lack CTL2 and vice versa. We will employ CTL1/2 mutants, siRNA and specific antibodies to demonstrate for the first time that CTL1 and CTL2 are choline and also ethanolamine transporters in mammalian systems. ii. CTL1 and CTL2 regulate mitochondrial function-Our preliminary data suggest that the luck of CTL1 induces mitophagy and fragmentation of mitochondrial networks. We propose that CTL1 regulate mitochondrial fusion-fission processes. We will investigate mechanisms of mitochondrial fusion and metabolism (electron transport complexes, ATP synthesis, ROS production, membrane potential, etc.) in CTL1 and CTL2 deficient and over-expressing cells. The initial findings will be corroborated in mitochondria and primary cells isolated from CTL1 and/or CTL2 knockout mice. We expect to demonstrate for the first time that CTL1 and perhaps CTL2 are critical regulators of mitochondrial turnover and mitochondrial energy homeostasis. iii. CTL1 and CTL2 couple phospholipid synthesis with the whole-body energy metabolism-CTL1 and CTL2 knockout mice were produced and characterized by the International Mouse Phenotyping Consortium. Reduced body weight and increased muscle/fat ratio are common features of CTL1 and CTL2 knockout mice. We will characterize CTL1 mice in full detail and compare to better known CTL2 mice, including the regulation of the  Kennedy pathway, lipid synthesis and energy metabolism in skeletal muscle, liver and adipose tissue, applying protocols extensively used in previous studies of our Pcyt2 knockout mice (Pcyt2 is the main regulatory enzyme in the CDP-ethanolamine Kennedy pathway).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characteristics and novel functions of SLC44A transporters
  • 批准号:
    RGPIN-2020-04573
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2021
  • 负责人:
    Bakovic, Marica
  • 依托单位:
Characteristics and novel functions of SLC44A transporters
  • 批准号:
    RGPIN-2020-04573
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2020
  • 负责人:
    Bakovic, Marica
  • 依托单位:
Regulation and Transport Mechanism of Choline Transporter-Like Protein 1 (CTL1/SLC44A1)
  • 批准号:
    RGPIN-2015-05580
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2019
  • 负责人:
    Bakovic, Marica
  • 依托单位:
Regulation and Transport Mechanism of Choline Transporter-Like Protein 1 (CTL1/SLC44A1)
  • 批准号:
    RGPIN-2015-05580
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2018
  • 负责人:
    Bakovic, Marica
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
miR-2796和novel_13靶向磷脂酶C基因调控Q烟粉虱高温耐受性的分子机制
  • 批准号:
    32402377
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    戴恬美
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位: